# US 2022/0033358 A1 · Methods of producing pyrazole compounds

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0033358 A1
- Document ID: US20220033358A1
- Status: Published application
- Kind: A1
- Application number: 17/277,036
- Filed: 2019-09-21
- Published: 2022-02-03
- Earliest claimed: 2018-09-22
- Assignees: Torrent Pharmaceuticals Limited
- Applicants: Torrent Pharmaceuticals Limited
- Inventors: Ramesh Chandra GUPTA; Mohan SINGARAVEL; Laxmikant CHHIPA; Ashok KASUNDRA
- Web page: https://patentgrep.com/patent/US20220033358A1

## CPC

- C07D 231/12: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The present invention is directed to methods of producing substituted pyrazole based compounds through novel intermediates and unique processes for preparing such intermediates which enables synthesis of final product through commercially viable route of synthesis. The present invention is also directed to novel methods of producing substituted pyrazole based thyroid like compounds, and solid forms of 3-{4-[(7-hydroxy-6-methyl-indan-4-yl)methyl]-3,5-dimethyl-1H-pyrazol-1-yl}-propanoic acid, its pharmaceutical compositions, and methods of preparation thereof.

## Claims

### Claim 1

A method for producing substituted pyrazole compound of Formula (I):
wherein:
R1, R2 and R3 are each independently selected from H, C1-6 alkyl, C1-6 alkoxy, or halogen;
R4 is selected from H, C1-10 saturated or unsaturated alkyl, C1-10 substituted or unsubstituted arylalkyl, C3-10 cycloalkyl, aryl, heteroaryl, C1-10 alkyl silyl, C1-10 alkyl silyl ethers, substituted or unsubstituted haloalkyl, or C1-20 alkyl tricyclic;
n is 1 to 5;
or its pharmaceutically acceptable salts, solvates, co-crystals, and hydrates thereof;
comprising
condensing a compound of Formula (XIX),
wherein R2, R3, R4 and n are as defined above; with a compound of Formula (XX),
wherein R is H or Pg1;
wherein Pg1 is hydroxy protecting group, and R1 is as defined above; in the presence of a condensing agent to obtain a compound of Formula (VIIIa),
wherein R, R1, R2, R3, R4 and n are as defined above; and optionally deprotecting and/or hydrolysing the compound of Formula (VIIIa) to yield substituted pyrazole compound of Formula (I).

### Claim 2 (depends on 1)

The method according to claim 1, wherein the substituents R1, R2, and R3 are methyl; R4 is H or C1-6 alkyl; n is 2; and Pg1 is methyl or benzyl.

### Claim 3 (depends on 1)

The method according to claim 1, wherein the condensing agent is selected from the group comprising formaldehyde, paraformaldehyde, 1,3,5-trioxane, or mixtures thereof.

### Claim 4 (depends on 1)

The method according to claim 1, wherein the condensation of a compound of Formula (XIX) with a compound of Formula (XX) is carried out optionally in the presence of acid catalyst selected from hydrochloric acid, sulphuric acid, p-toluenesulfonic acid, zinc chloride, or tin(II) chloride.

### Claim 5 (depends on 1)

The method according to claim 1, wherein the condensation reaction is carried out in the presence of a solvent selected from acetic acid, N,N-dimethylformamide, N,N-dimethylacetamide, dimethylsulphoxide, acetonitrile, N-methylpyrrolidone, cyclohexane, toluene, xylene or benzene.

### Claim 6 (depends on 1)

The method according to claim 1, wherein the deprotection of a compound of Formula (VIIIa) is carried out in the presence of boron tribromide or palladium on carbon.

### Claim 7 (depends on 1)

The method according to claim 1, wherein the hydrolysis of a compound of Formula (VIIIa) is carried out in the presence of a base selected from lithium hydroxide, sodium hydroxide, potassium hydroxide, magnesium hydroxide, sodium carbonate, potassium carbonate, cesium carbonate, magnesium carbonate, sodium bicarbonate, and potassium bicarbonate.

### Claim 8

A method for producing a compound of Formula (XIX),
wherein:
R2 and R3 are each independently selected from H, C1-6 alkyl, C1-6 alkoxy, or halogen;
R4 is selected from H, C1-10 saturated or unsaturated alkyl, C1-10 substituted or unsubstituted arylalkyl, C3-10 cycloalkyl, aryl, heteroaryl, C1-10 alkyl silyl, C1-10 alkyl silyl ethers, substituted or unsubstituted haloalkyl, or C1-20 alkyl tricyclic;
n is 1 to 5;
comprising
condensing a compound of Formula (XXI),
wherein R2 and R3 are as defined above; with a compound of Formula (VII),
wherein R4 and n are as defined above, and X is a leaving group; to obtain the compound of Formula (XIX).

### Claim 9 (depends on 8)

The method according to claim 8, wherein the substituents R2 and R3 are methyl; R4 is H or C1-6 alkyl; n is 2; and X is Cl or Br.

### Claim 10 (depends on 8)

The method according to claim 8, wherein the condensation of a compound of Formula (XXI) with a compound of Formula (VII) is carried out in the presence of a base selected from lithium hydroxide, sodium hydroxide, potassium hydroxide, magnesium hydroxide, sodium carbonate, potassium carbonate, cesium carbonate, magnesium carbonate, sodium bicarbonate, and potassium bicarbonate.

### Claim 11 (depends on 8)

The method according to claim 8, wherein the condensation reaction is carried out in the presence of a solvent selected from N,N-dimethylformamide, N,N-dimethylacetamide, dimethylsulphoxide, acetonitrile, and N-methylpyrrolidone.

### Claim 12 (depends on 8)

The method according to claim 8, wherein the condensation reaction is carried out in the presence of phase-transfer catalyst selected from quaternary ammonium salts, phosphonium salts, crown ethers, polyethylene glycols and combinations thereof.

### Claim 13

A method for producing substituted pyrazole compound of Formula (I):
wherein:
R1, R2 and R3 are each independently selected from H, C1-6 alkyl, C1-6 alkoxy, or halogen;
R4 is selected from H, C1-10 saturated or unsaturated alkyl, C1-10 substituted or unsubstituted arylalkyl, C3-10 cycloalkyl, aryl, heteroaryl, C1-10 alkyl silyl, C1-10 alkyl silyl ethers, substituted or unsubstituted haloalkyl, or C1-20 alkyl tricyclic;
n is 1 to 5;
or its pharmaceutically acceptable salts, solvates, co-crystals, and hydrates thereof;
comprising
condensing a compound of Formula (XX),
wherein R is H or Pg1,
wherein Pg1 is hydroxy protecting group, and R1 is as defined above; with a compound of Formula (XXII),
wherein R2 and R3 are as defined above; in the presence of a condensing agent to obtain a compound of Formula (VIb),
wherein R, R1, R2, and R3 are as defined above; cyclizing the compound of Formula (VIb) with hydrazine to yield a compound of Formula (VIc),
wherein R, R1, R2, and R3 are as defined above; and converting the compound of Formula (VIc) to substituted pyrazole compound of Formula (I).

### Claim 14 (depends on 13)

The method according to claim 13, wherein the substituents R2, and R3 are methyl; R4 is H or C1-6 alkyl; n is 2; and Pg1 is methyl or benzyl.

### Claim 15 (depends on 13)

The method according to claim 13, wherein the condensing agent is selected from the group comprising formaldehyde, paraformaldehyde, 1,3,5-trioxane, or mixtures thereof.

### Claim 16 (depends on 13)

The method according to claim 13, wherein the condensation of a compound of Formula (XX) with a compound of Formula (XXII) is carried out optionally in the presence of acid catalyst selected from hydrochloric acid, sulphuric acid, p-toluenesulfonic acid, zinc chloride, or tin(II) chloride.

### Claim 17 (depends on 13)

The method according to claim 13, wherein the condensation reaction is carried out in the presence of a solvent selected from acetic acid, N,N-dimethylformamide, N,N-dimethylacetamide, dimethylsulphoxide, acetonitrile, N-methylpyrrolidone, cyclohexane, toluene, xylene or benzene.

### Claim 18

A method for producing substituted pyrazole compound of Formula (I):
wherein:
R1, R2 and R3 are each independently selected from H, C1-6 alkyl, C1-6 alkoxy, or halogen;
R4 is selected from H, C1-10 saturated or unsaturated alkyl, C1-10 substituted or unsubstituted arylalkyl, C3-10cycloalkyl, aryl, heteroaryl, C1-10 alkyl silyl, C1-10 alkyl silyl ethers, substituted or unsubstituted haloalkyl, or C1-20 alkyl tricyclic;
n is 1 to 5;
or its pharmaceutically acceptable salts, solvates, co-crystals, and hydrates thereof;
comprising
condensing a compound of Formula (XX),
wherein R is H or Pg1;
wherein Pg1 is hydroxy protecting group, and R1 is as defined above; with a compound of Formula (XXIII),
wherein IV, and R3 are as defined above and R5 is H or Pg3;
wherein Pg3 is amino protecting group; in the presence of a condensing agent to obtain a compound of Formula (XXIV),
wherein R, R1, R2, R3, and R5 are as defined above; optionally deprotecting the compound of Formula (XXIV) to yield a compound of Formula (VIc),
wherein R, R1, R2, and R3 are as defined above; and converting the compound of Formula (VIc) to substituted pyrazole compound of Formula (I).

### Claim 19 (depends on 18)

The method according to claim 18, wherein the substituents R1, R2, and R3 are methyl; R4 is H or C1-6 alkyl; n is 2.

### Claim 20 (depends on 18)

The method according to claim 18, wherein the condensing agent is selected from the group comprising formaldehyde, paraformaldehyde, 1,3,5-trioxane, or mixtures thereof.

### Claim 21 (depends on 18)

The method according to claim 18, wherein the condensation of a compound of Formula (XX) with a compound of Formula (XXIII) is carried out optionally in the presence of acid catalyst selected from hydrochloric acid, sulphuric acid, p-toluenesulfonic acid, zinc chloride, or tin(II) chloride.

### Claim 22 (depends on 18)

The method according to claim 18, wherein the condensation reaction is carried out in the presence of a solvent selected from acetic acid, N,N-dimethylformamide, N,N-dimethylacetamide, dimethylsulphoxide, acetonitrile, N-methylpyrrolidone, cyclohexane, toluene, xylene or benzene.

### Claim 23

A method for producing substituted pyrazole compound of Formula (I):
wherein:
R1, R2 and R3 are each independently selected from H, C1-6 alkyl, C1-6 alkoxy, or halogen;
R4 is selected from H, C1-10 saturated or unsaturated alkyl, C1-10 substituted or unsubstituted arylalkyl, C1-10 alkyl silyl, C1-10 alkyl silyl ethers, substituted or unsubstituted haloalkyl, or C1-20 alkyl tricyclic;
n is 1 to 5;
or its pharmaceutically acceptable salts, solvates, co-crystals, and hydrates thereof;
comprising
condensing a compound of Formula (XXV),
wherein R2, R3 and n are as defined above, and R6 is selected from mono or di-carboxylic acid, acid chloride, ester, nitrile, aldehyde, alcohol, amide, alkyl, alkenyl, alkynyl, alkyl halide, or keto group; with a compound of Formula (XX),
wherein R is H or Pg′,
wherein Pg1 is hydroxy protecting group, and R1 is as defined above; in the presence of a condensing agent to obtain a compound of Formula (XVIIIa),
wherein R, R1, R2, R3, R4, R6 and n are as defined above; optionally converting the compound of Formula (XVIIIa) to a compound of Formula (VIIIa),
wherein R, R1, R2, R3, R4, and n are as defined above; and optionally deprotecting and/or hydrolysing the compound of Formula (VIIIa) to yield substituted pyrazole compound of Formula (I).

### Claim 24 (depends on 23)

The method according to claim 23, wherein the substituents R1, R2, and R3 are methyl; R4 is H or C1-6 alkyl; n is 2; and Pg1 is methyl or benzyl.

### Claim 25 (depends on 23)

The method according to claim 23, wherein the condensing agent is selected from the group comprising formaldehyde, paraformaldehyde, 1,3,5-trioxane, or mixtures thereof.

### Claim 26 (depends on 23)

The method according to claim 23, wherein the condensation of a compound of Formula (XXV) with a compound of Formula (XX) is carried out optionally in the presence of acid catalyst selected from hydrochloric acid, sulphuric acid, p-toluenesulfonic acid, zinc chloride, or tin(II) chloride.

### Claim 27 (depends on 23)

The method according to claim 23, wherein the condensation reaction is carried out in the presence of a solvent selected from acetic acid, N,N-dimethylformamide, N,N-dimethylacetamide, dimethylsulphoxide, acetonitrile, N-methylpyrrolidone, cyclohexane, toluene, xylene or benzene.

### Claim 28

A method for producing a compound of Formula (IX),
wherein R1 is selected from H, C1-6 alkyl, C1-6 alkoxy, and halogen;
comprising
protecting a compound of Formula (XIII),
wherein IV is as defined above; with a suitable protecting group to obtain a compound of Formula (XIV),
wherein R1 as defined above and Pg2 is hydroxy protecting group selected from tosyl or benzoyl;
reacting a compound of Formula (XIV) with 2,2-dimethyl-1,3-dioxane-4,6-dione to obtain a compound of Formula (XV),
wherein R1 and Pg2 are as defined above; cyclizing the compound of Formula (XV) to obtain a compound of Formula (XVI),
wherein R1 and Pg2 are as defined above; deprotecting the compound of Formula (XVI) to obtain a compound of Formula (XVII),
wherein R1 are as defined above; and reducing the compound of Formula (XVII) to yield a compound of Formula (IX),
[OR]
reducing the compound of Formula (XVI),
wherein R1 are as defined above; to obtain a compound of Formula (XVIa),
wherein IV and Pg2 are as defined above; and deprotecting the compound of Formula (XVIa) to obtain a compound of Formula (IX).

### Claim 29 (depends on 28)

The method according to claim 28, wherein the substituent R1 is methyl.

### Claim 30 (depends on 28)

The method according to claim 28, wherein the protection of a compound of Formula (XIII) is carried out in the presence of a base selected from lithium hydroxide, sodium hydroxide, potassium hydroxide, magnesium hydroxide, sodium carbonate, potassium carbonate, cesium carbonate, magnesium carbonate, sodium bicarbonate and potassium bicarbonate.

### Claim 31 (depends on 28)

The method according to claim 28, wherein the reaction of a compound of Formula (XIV) with 2,2-dimethyl-1,3-dioxane-4,6-dione is carried out in the presence of a base selected from pyridine, trimethylamine, triethylamine, diethylamine, diisopropylethylamine, imidazoles, triethanolamine, morpholine, and N-methyl morpholine.

### Claim 32 (depends on 28)

The method according to claim 28, wherein the cyclization of compound of Formula (XV) is carried out in the presence of thionyl chloride.

### Claim 33 (depends on 28)

The method according to claim 28, wherein the cyclization of compound of Formula (XV) is carried out in the presence of Lewis acid selected from zinc chloride, zinc iodide, aluminium chloride, aluminium bromide, and boron trifluoride etherate.

### Claim 34 (depends on 28)

The method according to claim 28, wherein the deprotection of compound of Formula (XVI) or (XVIa) is carried out in the presence of a base selected from lithium hydroxide, sodium hydroxide, potassium hydroxide, magnesium hydroxide, sodium carbonate, potassium carbonate, cesium carbonate, magnesium carbonate, sodium bicarbonate, and potassium bicarbonate.

### Claim 35 (depends on 28)

The method according to claim 28, wherein the reduction of compound of Formula (XVI) or (XVII) is carried out in the presence of a reducing agent selected from sodium borohydride, sodium triacetoxyborohydride, lithium borohydride, diisobutylaluminium hydride, lithium aluminium hydride, triethylsilane, and palladium on carbon.
